EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
CH7233163 Sensitive: D – Preclinical
|
CH7233163 Sensitive: D – Preclinical
|
EGFR C797S + EGFR T790M + EGFR L858R
|
LUAD
|
EGFR C797S + EGFR T790M + EGFR L858R
|
LUAD
|
brigatinib + vorinostat Sensitive: D – Preclinical
|
brigatinib + vorinostat Sensitive: D – Preclinical
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
OBX02-011 Sensitive: D – Preclinical
|
OBX02-011 Sensitive: D – Preclinical
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
panitumumab + WX-0593 Sensitive: D – Preclinical
|
panitumumab + WX-0593 Sensitive: D – Preclinical
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
HBI-2376 Sensitive: D – Preclinical
|
HBI-2376 Sensitive: D – Preclinical
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
H002 Sensitive: D – Preclinical
|
H002 Sensitive: D – Preclinical
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
EGFR C797S + EGFR T790M + EGFR L858R
|
NSCLC
|
14aj Sensitive: D – Preclinical
|
14aj Sensitive: D – Preclinical
|